China Pharmaceuticals and Healthcare Report

Jul, 2016   |   161  Pages   |   BMI Pharmaceuticals and Healthcare   |   Format : PDF

BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments 'in China, for China'. The local industry, while still largely focused on generic drugs, has started to shift towards developing innovative treatments. Together with the partnerships formed with multinational drugmakers, investments into research by Chinese firms will grow and contribute to the country's flourishing drug discovery sector.

Headline Expenditure Projections
-Pharmaceuticals: CNY688bn (USD109bn) in 2015 to CNY768bn (USD116bn) by 2016; +11.7% in local currency terms and +5.6% in USD terms.
-Healthcare: CNY3,965bn (USD631bn) in 2015 to CNY4,451bn (USD670bn) in 2015; +12.3% in local currency and +6.2% in USD terms.

BMI Industry View . 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (China 2014-2020) . . . 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast .. 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (China 2012-2020) 14
Healthcare Market Forecast ........ 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (China 2012-2020) . 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (China 2012-2020) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (China 2012-2020) . 20
Prescription Drug Market Forecast ......... 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (China 2012-2020) 22
Patented Drug Market Forecast ... 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (China 2012-2020) . . . 24
Generic Drug Market Forecast .... 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (China 2012-2020) 26
China ..... 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (China 2012-2020) . 29
Pharmaceutical Trade Forecast ... 30
Table: Pharmaceutical Trade Data And Forecasts (China 2014-2020) . . . 32
Table: Pharmaceutical Trade Data And Forecasts local currency (China 2014-2020) . . . 32
Industry Risk/Reward Index ..... 33
Asia Pacific Risk/Reward Index - Q4 2016 . 33
China Risk/Reward Index . 40
Rewards 40
Risks ..... 40
Regulatory Review ......... 42
Regulatory Regime ........ 42
Table: Important China GMP Deadlines . . . 46
Intellectual Property Issues ........ 48
Pricing Regime .. 54
Reimbursement Regime .. 56
China - 13th Five-Year Plan To Reinforce Existing Trends . 59
Market Overview . 63
Healthcare Sector ......... 63
Table: Healthcare Resources (China 2010-2015) . . 66
Table: Healthcare Personnel (China 2010-2015) . . 66
Table: Healthcare Activity (China 2010-2015) . 67
Research & Development .......... 74
Table: Selected List Of MNC With R&D Bases In China . . 75
Table: Selected List Of Collaboration In R&D Operations In China . . 78
Clinical Trials ... 79
Epidemiology .... 80
Table: Estimated Number Of New Cases Of Cancer In China . 83
Competitive Landscape . 84
Research-Based Industry 84
Table: Companies Represented by RDPAC 84
Table: Multinational Market Activity . . . 85
Generic Drugmakers ..... 87
Pharmaceutical Distribution ...... 87
Company Profile .. 89
AstraZeneca ....... 89
Bayer ..... 94
China Shijiazhuang Pharmaceutical Group .......... 98
Eli Lilly 100
GlaxoSmithKline .......... 104
North China Pharmaceutical Corporation .......... 109
Novartis 112
Merck & Co ...... 116
Merck KGaA .... 119
Pfizer ... 122
Roche ... 125
Sanofi ... 129
Shanghai Pharmaceutical ......... 133
Sinopharm ........ 136
13th Five Year Plan ....... 139
13th Five-Year Plan: Key Points 139
Summary Of Contents .. 139
Chapter 1: Overview .... 140
Table: Targets . . 140
Chapter 2: Innovation To Drive Development .... 141
Chapter 3: Economic Institutions ......... 142
Chapter 4: Modernisation Of The Agricultural Sector .... 143
Chapter 5: Industries ... 144
Chapter 6: Expand The Network Economy ........ 145
Chapter 7: Build A Modern Infrastructure Network ....... 145
Chapter 8: New-Type Urbanisation ...... 146
Chapter 9: Coordination Of Regional Development ....... 147
Chapter 10: Environmental Protection .. 148
Chapter 11: Continue Opening Up ....... 148
Others: .......... 148
Demographic Forecast 150
Table: Population Headline Indicators (China 1990-2025) . . . 151
Table: Key Population Ratios (China 1990-2025) 151
Table: Urban/Rural Population & Life Expectancy (China 1990-2025) . . 152
Table: Population By Age Group (China 1990-2025) . 152
Table: Population By Age Group % (China 1990-2025) . . 153
Glossary .. 155
Methodology ...... 157
Pharmaceutical Expenditure Forecast Model .... 157
Healthcare Expenditure Forecast Model 157
Notes On Methodology . 158
Risk/Reward Index Methodology .......... 159
Index Overview 160
Table: Pharmaceutical Risk/Reward Index Indicators 160
Indicator Weightings ... 161
China Petrochemicals Report
The China Petrochemicals Report has been researched at source, and features BMI Research's market assessment and independent forecasts for key petrochemicals sub-sectors. The report also analyses the impact of regulatory changes, recent developments and the background macroeconomic outlook and featu
China Oil and Gas Report
BMI View: China's long-term crude oil and liquids output will remain on a firm downtrend as low oil prices slowdown exploration and render certain high-cost mature and unconventional plays uneconomic. Outlook is more positive for natural gas, as the government seeks to increase the share of ga
China Telecommunications Report
BMI View: Operator strategies will continue to chime with the government's directive to drive uptake of wireline broadband and machine-to-machine (M2M) connections. However, this means that even as subscription numbers rise, the prices of basic services will be compressed and operators will derive p
Global and China Lithium Carbonate Industry Report, 2016-2020
Driven by a surge in sales volume of new energy vehicles in China, the upstream material- lithium carbonate was in short supply in the fourth quarter of 2015 with soaring prices. Global lithium carbonate output increased by 12.3% year on year to 202,800 tons in 2015 and is expected to arrive at 244,
China trolleybus manufacturing industry, 2017
China trolleybus manufacturing industry, 2017 is valuable for anyone who wants to invest in the trolleybus manufacturing industry, to get Chinese investments; to import into China or export from China, to build factories and take advantage of lower costs in China, to partner with one of the key Chin

Select a Licence type

Custom Research

We are known to provide exact requirements. Try our CUSTOM RESEARCH option and get the exact search result you are searching for.

Contact Us

Postal Address:
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi, Navi Mumbai - 400703 , INDIA .
Telephone: +91 22 27810772, 27810773
Email: info@marketreportsonchina.com
Fax Number: +91 22 27812707

Follow Us On: